β-Arrestin2 Regulates Lysophosphatidic Acid-Induced Human Breast Tumor Cell Migration and Invasion via Rap1 and IQGAP1

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Alemayehu, Mistre ^a   Dragan, Magdalena ^a   Pape, Cynthia ^a   Siddiqui, Iram ^a   Sacks, David B ^b   Di Guglielmo, Gianni M ^a   Babwah, Andy V ^a   Bhattacharya, Moshmi ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; MESSENGER RNA; RAP1 PROTEIN; RAP1A PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

APOPTOSIS; ARRESTINS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYSOPHOSPHOLIPIDS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RAS GTPASE-ACTIVATING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS;

EID: 84873539187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056174     Document Type: Article

References (63)

1. Weigelt B, Peterse JL, van 't Veer LJ, (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602.
2. Lefkowitz RJ, Shenoy SK, (2005) Transduction of receptor signals by beta-arrestins. Science 308: 512-517.
3. Shukla XK, Lefkowitz RJ, (2011) Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 36: 457-469.
4. DeFea KA, (2011) Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal 23: 621-629.
5. Min J, Defea K, (2011) beta-arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Mol Pharmacol 80: 760-768.
6. Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, et al. (2005) beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 280: 8041-8050.
7. Sun Y, Cheng Z, Ma L, Pei G, (2002) Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277: 49212-49219.
8. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, et al. (2007) Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282: 20634-20646.
9. Cotton M, Claing A, (2009) G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 21: 1045-1053.
10. Mythreye K, Blobe GC, (2009) The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci U S A 106: 8221-8226.
11. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, et al. (2007) Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem 282: 11329-11338.
12. Matsubayashi J, Takanashi M, Oikawa K, Fujita K, Tanaka M, et al. (2008) Expression of G protein-coupled receptor kinase 4 is associated with breast cancer tumourigenesis. J Pathol 216: 317-327.
13. Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, et al. (2009) Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811.
14. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, et al. (2006) Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 103: 1492-1497.
15. Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM, (2008) Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 180: 5699-5706.
16. Zou L, Yang R, Chai J, Pei G, (2008) Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J 22: 355-364.
17. Ma L, Pei G, (2007) Beta-arrestin signaling and regulation of transcription. J Cell Sci 120: 213-218.
18. Lakshmikanthan V, Zou L, Kim JI, Michal A, Nie Z, et al. (2009) Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci U S A 106: 9379-9384.
19. Shenoy SK, Han S, Zhao YL, Hara MR, Oliver T, et al. (2011) beta-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression. Oncogene 22: 256-265.
20. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, et al. (2009) Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7: 1064-1077.
21. Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, et al. (2011) Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Res Treat 130: 791-807.
22. Zajac M, Law J, Cvetkovic DD, Pampillo M, McColl L, et al. (2011) GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness. PLoS One 6: e21599.
23. Luttrell LM, Gesty-Palmer D, (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62: 305-330.
24. Urs NM, Jones KT, Salo PD, Severin JE, Trejo J, et al. (2005) A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors. J Cell Sci 118: 5291-5304.
25. Watterson KR, Lanning DA, Diegelmann RF, Spiegel S, (2007) Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen 15: 607-616.
26. Mills GB, Moolenaar WH, (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591.
27. Moolenaar WH, van Meeteren LA, Giepmans BN, (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870-881.
28. Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clezardin P, et al. (2006) The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc Natl Acad Sci U S A 103: 9643-9648.
29. Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, et al. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15: 539-550.
30. Du J, Sun C, Hu Z, Yang Y, Zhu Y, et al. (2010) Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling. PlosOne 5(12): e15940.
31. Chen M, Towers LN, O'Connor KL, (2007) LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol 292: C1927-1933.
32. Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, et al. (2002) Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4: 547-555.
33. Herrmann C, Horn G, Spaargaren M, Wittinghofer A, (1996) Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J Biol Chem 271: 6794-6800.
34. Frische EW, Zwartkruis FJ, (2010) Rap1, a mercenary among the Ras-like GTPases. Dev Biol 340(1): 1-9.
35. Goto M, Mitra RS, Liu M, Lee J, Henson BS, et al. (2010) Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck. Clin Cancer Res 16: 65-76.
36. Hattori M, Minato N, (2003) Rap1 GTPase: functions, regulation, and malignancy. J Biochem 134: 479-484.
37. Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, et al. (2011) Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. Breast Cancer Res Treat 129(2): 361-372.
38. Itoh M, Nelson CM, Myers CA, Bissell MJ, (2007) Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. Cancer Res 67: 4759-4766.
39. Brown MD, Sacks DB, (2006) IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol 16: 242-249.
40. Mataraza JM, Briggs MW, Li Z, Entwistle A, Ridley AJ, et al. (2003) IQGAP1 promotes cell motility and invasion. J Biol Chem 278: 41237-41245.
41. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K, (2005) IQGAP1: a key regulator of adhesion and migration. J Cell Sci 118: 2085-2092.
42. Du J, Sun C, Hu Z, Yang Y, Zhu Y, et al. (2010) Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling. PLoS One 5: e15940.
43. Fang X, Yu S, Bast RC, Liu S, Xu HJ, et al. (2004) Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem 279: 9653-9661.
44. Stahle M, Veit C, Bachfischer U, Schierling K, Skripczynski B, et al. (2003) Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci 116: 3835-3846.
45. Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL, (1998) Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J 17: 5905-5912.
46. Kimura T, Mogi C, Sato K, Tomura H, Ohta H, et al. (2011) p2y5/LPA(6) attenuates LPA(1)-mediated VE-cadherin translocation and cell-cell dissociation through G(12/13) protein-Src-Rap1. Cardiovasc Res 92: 149-158.
47. Jeong HW, Li Z, Brown MD, Sacks DB, (2007) IQGAP1 binds Rap1 and modulates its activity. J Biol Chem 282: 20752-20762.
48. Fukata M, Watanabe T, Noritake J, Nakagawa M, Yamaga M, et al. (2002) Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 109: 873-885.
49. Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB, (2008) IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J Biol Chem 283: 1008-1017.
50. Ridley AJ, (2011) Life at the leading edge. Cell 145: 1012-1022.
51. Bos JL, (2005) Linking Rap to cell adhesion. Curr Opin Cell Biol 17: 123-128.
52. Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M, et al. (2007) Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A 104: 12011-12016.
53. White CD, Erdemir HH, Sacks DB (2011) IQGAP1 and its binding proteins control diverse biological functions. Cell Signalling.
54. Hanson SM, Cleghorn WM, Francis DJ, Vishnivetskiy SA, Raman D, et al. (2007) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol 368: 375-387.
55. Good MC, Zalatan JG, Lim WA, (2011) Scaffold proteins: hubs for controlling the flow of cellular information. Science 332: 680-686.
56. Logue JS, Scott JD, (2010) Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J 21: 4370-4375.
57. Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, et al. (2008) The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol 181: 985-998.
58. Li J, Ghio AJ, Cho SH, Brinckerhoff CE, Simon SA, et al. (2009) Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ Health Perspect 117: 400-409.
59. Bailey CL, Kelly P, Casey PJ, (2009) Activation of Rap1 promotes prostate cancer metastasis. Cancer Res 69: 4962-4968.
60. Mitra RS, Goto M, Lee JS, Maldonado D, Taylor JM, et al. (2008) Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res 68: 3959-3969.
61. Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR, (2009) Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility. BMC Cancer 9: 331.
62. McSherry EF, Brannan K, Hudson L, Hill AD, Hopkins AM, (2011) Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 13: R31.
63. Dorfleutner A, Stehlik C, Zhang J, Gallick GE, Flynn DC, (2007) AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells. J Cell Physiol 213: 740-749.